G. Stauder

Inhibition of TGF- <i>β</i> 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies

Peter Hau, Piotr Jachimczak, Reimar Schlingensiepen et al. · Oligonucleotides · 2007 · 217 citations

Medicine, Oncology, Pharmacology +13

Intracerebral and Intrathecal Infusion of the TGF-β2-Specific Antisense Phosphorothioate Oligonucleotide AP 12009 in Rabbits and Primates: Toxicology and Safety

Reimar Schlingensiepen, Michael Goldbrunner, Mara Szyrach et al. · Oligonucleotides · 2005 · 68 citations

Medicine, Pharmacology, Toxicology +9

The TGF-beta1 antisense oligonucleotide AP 11014 for the treatment of non-small cell lung, colorectal and prostate cancer: Preclinical studies

K.-H. Schlingensiepen, Astrid Bischof, T. Egger et al. · Journal of Clinical Oncology · 2004 · 31 citations

Medicine, Immunology, Oncology +16

Specific therapy for high-grade glioma by convection-enhanced delivery of the TGF-β2 specific antisense oligonucleotide AP 12009

Ulrich Bogdahn, Peter Hau, Alexander Brawanski et al. · Journal of Clinical Oncology · 2004 · 20 citations

Medicine, Neurosurgery, Oncology +17